Jan 23 (Reuters) - Luye Pharma Group Ltd:
* ‍UPDATES ON PHASE II CLINICAL TRIAL IN CHINA FOR ANSOFAXINE HYDROCHLORIDE EXTENDED RELEASE TABLETS​
* PRELIMINARY RESULTS OF PHASE II TRIAL MET PRIMARY EFFICACY ENDPOINT Source text for Eikon: Further company coverage:
 